161 related articles for article (PubMed ID: 21196243)
21. T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells.
De Smedt M; Leclercq G; Vandekerckhove B; Kerre T; Taghon T; Plum J
Haematologica; 2011 May; 96(5):646-54. PubMed ID: 21330325
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of hematopoietic differentiation between human embryonic stem cell lines.
Melichar H; Li O; Ross J; Haber H; Cado D; Nolla H; Robey EA; Winoto A
PLoS One; 2011; 6(5):e19854. PubMed ID: 21603627
[TBL] [Abstract][Full Text] [Related]
24. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.
Amabile G; Welner RS; Nombela-Arrieta C; D'Alise AM; Di Ruscio A; Ebralidze AK; Kraytsberg Y; Ye M; Kocher O; Neuberg DS; Khrapko K; Silberstein LE; Tenen DG
Blood; 2013 Feb; 121(8):1255-64. PubMed ID: 23212524
[TBL] [Abstract][Full Text] [Related]
25. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
[TBL] [Abstract][Full Text] [Related]
26. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
Zhu H; Kaufman DS
Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
28. [From stem cells to lymphocytes].
Melchers F
Z Rheumatol; 2009 May; 68(3):196-200, 202-4. PubMed ID: 19384553
[TBL] [Abstract][Full Text] [Related]
29. Pluripotent stem cell-derived natural killer cells for cancer therapy.
Knorr DA; Kaufman DS
Transl Res; 2010 Sep; 156(3):147-54. PubMed ID: 20801411
[TBL] [Abstract][Full Text] [Related]
30. Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.
Peters A; Burridge PW; Pryzhkova MV; Levine MA; Park TS; Roxbury C; Yuan X; Péault B; Zambidis ET
Int J Dev Biol; 2010; 54(6-7):965-90. PubMed ID: 20563986
[TBL] [Abstract][Full Text] [Related]
31. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
[TBL] [Abstract][Full Text] [Related]
32. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
Miller JS; Verfaillie C; McGlave P
Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells.
Hexum MK; Tian X; Kaufman DS
Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894
[TBL] [Abstract][Full Text] [Related]
34. Haematopoietic developmental potential of human pluripotent stem cell lines.
Tesařová L; Simara P; Stejskal S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
36. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.
Isgrò A; Marziali M; Sodani P; Gaziev J; Erer B; Polchi P; Paciaroni K; Roveda A; De Angelis G; Gallucci C; Alfieri C; Simone MD; Zinno F; Isacchi G; Adorno G; Lanti A; Leti W; Aiuti F; Fraboni D; Andreani M; Lucarelli G
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1557-66. PubMed ID: 20546907
[TBL] [Abstract][Full Text] [Related]
37. When CAR Meets Stem Cells.
Lee JM
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013813
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
[TBL] [Abstract][Full Text] [Related]
39. Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor.
Nakayama N; Fang I; Elliott G
Blood; 1998 Apr; 91(7):2283-95. PubMed ID: 9516126
[TBL] [Abstract][Full Text] [Related]
40. DL4-μbeads induce T cell lineage differentiation from stem cells in a stromal cell-free system.
Trotman-Grant AC; Mohtashami M; De Sousa Casal J; Martinez EC; Lee D; Teichman S; Brauer PM; Han J; Anderson MK; Zúñiga-Pflücker JC
Nat Commun; 2021 Aug; 12(1):5023. PubMed ID: 34408144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
